Acumen Pharmaceuticals (ABOS) Assets (2020 - 2026)
Acumen Pharmaceuticals' Assets came in at $116.01 million for Q2 2026, down 32.5% from $171.9 million a year earlier and down 13.2% from the prior quarter.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Acumen Pharmaceuticals' Assets was $122.83 million, down 48.6% from FY2024.
- Assets carries a five-year compound annual growth rate of 22.6% (FY2020 to FY2025).
- Going back by year, Assets was $238.99 million in FY2024 (-22.9%), $310.13 million in FY2023 (+57.8%), $196.59 million in FY2022 (-14.6%) and $230.33 million in FY2021 (+418.4%).
- The Q2 2026 figure represents the lowest quarterly Assets since Q2 2021.
- Year-over-year, Assets has declined for eight consecutive quarters, with an average decline of 33.1% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 418.4%), and the weakest in Q4 2025 (a decline of 48.6%).
- Business Quant data shows ABOS's Assets at $133.63 million (Q1 2026), $122.83 million (Q4 2025) and $142.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Acumen Pharmaceuticals | 147.03 Mn | -335.04 Mn | - | 116.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.01 Mn |
| Mar 31, 2026 | 133.63 Mn |
| Dec 31, 2025 | 122.83 Mn |
| Sep 30, 2025 | 142.22 Mn |
| Jun 30, 2025 | 171.90 Mn |
| Mar 31, 2025 | 204.48 Mn |
| Dec 31, 2024 | 238.99 Mn |
| Sep 30, 2024 | 266.98 Mn |
| Jun 30, 2024 | 288.91 Mn |
| Mar 31, 2024 | 300.97 Mn |
| Dec 31, 2023 | 310.13 Mn |
| Sep 30, 2023 | 286.37 Mn |
| Jun 30, 2023 | 177.41 Mn |
| Mar 31, 2023 | 187.86 Mn |
| Dec 31, 2022 | 196.59 Mn |
| Sep 30, 2022 | 203.26 Mn |
| Jun 30, 2022 | 211.68 Mn |
| Mar 31, 2022 | 220.09 Mn |
| Dec 31, 2021 | 230.33 Mn |
| Sep 30, 2021 | 234.85 Mn |
API Access
Acumen Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ABOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();